Genesis Healthcare, Inc. Stock Other OTC
Equities
GEN
US37185X1063
Healthcare Facilities & Services
Financials (USD)
Sales 2021 * | 3.46B | Sales 2022 * | - | Capitalization | 134K |
---|---|---|---|---|---|
Net income 2021 * | -22M | Net income 2022 * | - | EV / Sales 2021 * | 0.95 x |
Net Debt 2021 * | 3.28B | Net cash position 2022 * | - | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-0.01
x | P/E ratio 2022 * |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 46.99% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 21-01-31 | |
Public Communications Contact | - | - | |
Susan Overton
LAW | General Counsel | - | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 15-02-01 | |
John Randazzo
BRD | Director/Board Member | 69 | 21-03-01 |
Chairman | 79 | 21-03-01 |
1st Jan change | Capi. | |
---|---|---|
-14.25% | 85.02B | |
+14.46% | 82.37B | |
+9.37% | 29.29B | |
-11.40% | 17.21B | |
-0.36% | 16.7B | |
+0.22% | 15.5B | |
+4.32% | 12.15B | |
-2.34% | 12.13B | |
+32.69% | 12.12B |